Department of Rheumatology and Immunology, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen People's Hospital, Shenzhen 518020, Guangdong, China.
Integrated Chinese and Western Medicine Postdoctoral Research Station, Jinan University, Guangzhou 510632, China.
J Proteome Res. 2023 Jan 6;22(1):123-137. doi: 10.1021/acs.jproteome.2c00532. Epub 2022 Dec 12.
Dermatomyositis and polymyositis (DM/PM) are systemic autoimmune diseases characterized by proximal muscle weakness. The underlying pathogenetic mechanism of this disease remains under-researched. Here, using proteomics analysis, a great overlap of differentially expressed plasma exosomal proteins involved in the complement and coagulation cascade pathway, including FGA, FGB, FGG, C1QB, C1QC, and VWF, was identified in DM/PM patients versus healthy controls. Correlation analysis showed that the expression levels of complement-associated proteins (C1QB and C1QC) correlated positively with CRP, ESR, and platelet count. ROC curve analysis demonstrated that complement and coagulation cascade-associated proteins could be strong predictors for DM/PM. In addition, we also identified several other proteins that were differentially expressed in DM and PM. The selected candidate proteins were further validated by parallel reaction monitoring (PRM) and enzyme-linked immunosorbent assay (ELISA). Together, our findings indicate that these exosome-derived proteins might participate in microvascular damage in DM/PM through the activation of the complement and coagulation cascade pathway and function as biomarkers for the clinical diagnosis of DM/PM.
皮肌炎和多发性肌炎(DM/PM)是一种以近端肌肉无力为特征的系统性自身免疫性疾病。这种疾病的潜在发病机制仍未得到充分研究。在这里,通过蛋白质组学分析,在 DM/PM 患者与健康对照组之间鉴定出了涉及补体和凝血级联途径的差异表达血浆外泌体蛋白的大量重叠,包括 FGA、FGB、FGG、C1QB、C1QC 和 VWF。相关性分析表明,补体相关蛋白(C1QB 和 C1QC)的表达水平与 CRP、ESR 和血小板计数呈正相关。ROC 曲线分析表明,补体和凝血级联相关蛋白可能是 DM/PM 的强预测因子。此外,我们还鉴定出 DM 和 PM 中差异表达的其他几种蛋白质。通过平行反应监测(PRM)和酶联免疫吸附测定(ELISA)进一步验证了选定的候选蛋白。总之,我们的研究结果表明,这些外泌体衍生蛋白可能通过补体和凝血级联途径的激活参与 DM/PM 的微血管损伤,并作为 DM/PM 临床诊断的生物标志物。